Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Tobramycin for Infection Prophylaxis in Open Fractures
NCT03705962Phase 3Terminated
- Sponsor
- University of Virginia
- Start
- Jul 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tobramycin in Wound infection (WI), sponsored by University of Virginia. Primary endpoint: Presence of Wound Infection at 6 weeks. Started Jul 2015; status: terminated.
02
Drugs
tobramycin
03
Conditions
Wound infection (WI)
Beyond the preview
Go deeper on NCT03705962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03705962.